enerzair breezhaler
novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - astma - lyf til veikindi öndunarvegi sjúkdómum, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.
bemrist breezhaler
novartis europharm limited - indacaterol, mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - bemrist breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
zimbus breezhaler
novartis europharm limited - glycopyrronium bromide, indacaterol (acetate), mometasone furoate - astma - lyf til veikindi öndunarvegi sjúkdómum, - maintenance treatment of asthma in adults whose disease is not adequately controlled.
okedi
laboratorios farmacéuticos rovi, s.a. - risperidone - geðklofa - psycholeptics - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
dimethyl fumarate mylan
mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
terbinafin actavis tafla 250 mg
actavis group ptc ehf. - terbinafinum hýdróklóríð - tafla - 250 mg
ríson filmuhúðuð tafla 2 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 2 mg
ríson filmuhúðuð tafla 1 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 1 mg
ríson filmuhúðuð tafla 0,5 mg
teva b.v.* - risperidonum inn - filmuhúðuð tafla - 0,5 mg
postafen tafla 25 mg
campuspharma ab - meclozinum hýdróklóríð - tafla - 25 mg